Tiffany Muller Email

SVP Finance . Nouscom

Current Roles

Employees:
57
Revenue:
$8.8M
About
Nouscom is a private oncology company developing next generation immunotherapies. Nouscom's proprietary technology platform, Exovax, harnesses the full power of immune response by combining viral vectored genetic vaccines based on neoantigens with other immunomodulators. Nouscom is led by an experienced management team that has worked together for many years in previous successful enterprises, including IRBM/Merck and Okairos (acquired by GSK), and are veterans in the field of genetic vaccines. Nouscom, which was founded in 2015 and is headquartered in Basel, Switzerland with operations in Rome, Italy, is backed by international life sciences investors: 5AM, Abingworth, LSP (Life Sciences Partners) and Versant Ventures. For more information on Nouscom, please visit the company's website at www.nouscom.com
Nouscom Address
Bäumleingasse 18
BS, null
Nouscom Email

Past Companies

Nouscom AGSenior Vice President Finance
Nouscom AGVP of Finance
AramarkDirector of Investments - Higher Education

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.